Associations between brain-derived neurotrophic factor plasma levels and severity of the illness, recurrence and symptoms in depressed patients

Neuropsychobiology

Volumn 62, Issue 4, 2010, Pages 207-212

  Dell'osso, Liliana ^a   Del Debbio, Alessandro ^a   Veltri, Antonello ^a   Bianchi, Carolina ^a   Roncaglia, Isabella ^a   Carlini, Marina ^a   Massimetti, Gabriele ^a   Catena Dell'Osso, Mario ^a   Vizzaccaro, Chiara ^a   Marazziti, Donatella ^a   Piccinni, Armando ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Brain derived neurotrophic factor; Depersonalization derealization symptoms; Hamilton Rating Scale for Depression retardation factor score; Major depression, recurrence; plasma levels

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RATING SCALE; RECURRENT DISEASE; SLEEP DISORDER;

ADULT; AGED; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS;

EID: 77955519894     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319946     Document Type: Article

References (47)

1. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. A rch Gen Psychiatr y 1997; 54: 597-605.
2. Duman RS: Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromol Med 2004; 5:11-25.
3. Post RM: Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 2007; 41: 979-990.
4. Stein DJ, Daniels WM, Savitz J, Harvey BH: Brain-derived neurotrophic factor: the neu-rotrophin hypothesis of psychopathology. CNS Spectr 2008; 13: 945-949.
5. Yamamoto H, Gurney ME: Human platelets contain brain-derived neurotrophic factor. J Neurosci 1990; 10 : 3469-3478.
6. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, Sun B, Tandon NN: Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002; 87:728-734.
7. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P: The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005; 26: 115-123.
8. Karege F, Schwald M, Cisse M: Postnatal developmental profile of brain-derived neuro-trophic factor in rat brain and platelets. Neu-rosci Lett 2002; 328: 261-264.
9. Elfving B, Plougmann PH, Müller HK, Mathé AA, Rosenberg R, Wegener G: Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int J Neuropsychopharmacol, E-pub ahead of print.
10. Sen S, Duman R, Sanacora G: Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008; 64: 527-532.
11. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M: Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54:70-75.
12. Aydemir O, Deveci A, Taneli F: The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 261-265.
13. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, Karege F: Partial normalization of serum brain-derived neu-rotrophic factor in remitted patients after a major depressive episode. Neuropsychobiol-ogy 2005; 51 : 234-238.
14. Gonul A, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S: Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 2005; 255:381-386.
15. Lee BH, Kim H, Park SH, Kim YK: Decreased plasma BDNF level in depressive patients. J Af fect Disord 2007; 101: 239-244.
16. Piccinni A, Marazziti D, Catena M , Domenici L, Del Debbio A, Bianchi C, Mannari C, Martini C, Da Pozzo E, Schiavi E, Mariotti A, Roncaglia I, Palla A, Consoli G, Giovan-nini L, Massimetti G, Dell'Osso L: Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord 2008; 105: 279-283.
17. Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L, Ruber-to A, Tatarelli R, Nicoletti F, Girardi P, Shel-ton RC: Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with ser-traline, escitalopram, or venlafaxine. J Psy-chiatr Res 2009; 43: 247-254.
18. Marano CM, Phatak P, Vemulapalli UR, Sa-san A, Nalbandyan MR, Ramanujam S, Soekadar S, Demosthenous M, Regenold WT: Increased plasma concentration of brain-derived neurotrophic factor with elec-troconvulsive therapy: a pilot study in patients with major depression. J Clin Psychiatry 2007; 68:512-517.
19. Yoshimura R, Mitoma M, Sugita A, Hori H, Okamoto T, Umene W, Ueda N, Nakamura J: Ef fect s of paroxeti ne or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychophar-macol Biol Psychiatry 2007; 31:1034-1037.
20. Huang TL, Lee CT, Liu YL: Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepres-sants. J Psychiatr Res 2008; 42:521-525.
21. Piccinni A, Del Debbio A, Medda P, Bianchi C, Roncaglia I, Veltri A, Zanello S, Massimetti E, Origlia N, Domenici L, Marazziti D, Dell'Osso L: Plasma brain-derived neuro-trophic factor in treatment-resistant de pressed patients receiving electroconvulsive therapy. Eur Neuropsychopharmacol 2009; 19: 349-355.
22. Rizos EN, Rontos I, Laskos E, Arsenis G, Michalopoulou PG, Vasilopoulos D, Gournellis R, Lykouras L: Investigation of serum BDNF levels in drug-naive patients with schizo-phrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1308-1311.
23. Dell'Osso L, Carmassi C, Del Debbio A, Catena Dell'Osso M, Bianchi C, Da Pozzo, E, Origlia N, Domenici L, Massimetti G, Marazziti D, Piccinni A: Brain-derived neu-ro t ro p h ic f ac tor pla sm a le vels i n pa t ient s su f-fering from post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33:899-902.
24. Saito S, Watanabe K, Hashimoto E, Saito T: Low serum BDNF and food intake regulation: a possible explanation of the patho-physiology of eating disorders. Prog Neuro-psychopharmacol Biol Psychiatry 2009; 33: 312-316.
25. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G: Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactiv it y. Biol Psychiatry 2005; 57: 1068-1072.
26. Palomino A, Vallejo-Illarramendi A, González-Pinto A, Aldam A, González Gó-mez, C, Mosquera F, González-García G, Matute C: Decreased levels of plasma BDNF in first episode schizophrenia and bipolar disorder patients. Schizophr Res 2006; 86: 321-322.
27. de Oliveira GS, Ceresér KM, Fernandes BS, Kauer-Sant'anna M, Fries GR, Stertz L, Aguiar B, Pfaffenseller B, Kapczinski F: Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 2009; 43:1171-1174.
28. Gonul AS, Akdenz F, Taneli A, Donat O, Eker C, Vahip S: The effect of treatment on serum brain-derived neurotrophic factor in depressed patients. Eur Neuropsychophar-macol 2003; 3:S20-S23.
29. Monteleone P, Serritella C , Martiadis V, Maj M: Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord 2008; 10:95-100.
30. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Text Revision, ed 4. Washington, American Psychiatric Press, 2000.
31. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33.
32. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
33. Guy W: ECDEU Assessment Manual for Psy-chopharmacology. US Dept Health, Education, and Welfare Publication (ADM). Rock-ville, National Institute of Mental Health, 1976.
34. Benazzi F: Psychomotor changes in melancholic and atypical depression: 1976 unipolar and bipolar-II subtypes. Psychiatry Res 2002; 11 2 : 211-220.
35. Parker G: Classifying depression: should paradigms lost be regained? Am J Psychiatry 2000; 157:1195-1203.
36. Pintor L, Torres X, Navarro V, Martinez de Osaba MA, Matrai S, Gastó C: Corticotro-pin-releasing factor test in melancholic patients in depressed state versus recovery: a comparative study. Prog Neuropsychophar-macol Biol Psychiatry 2007; 31:1027-1033.
37. Pintor L, Torres X, Navarro V, Martinez de Osaba MA, Matrai S, Gastó C: Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin releasing factor test. Prog Neuropsycho-pharmacol Biol Psychiatr y 2009; 33: 463-469.
38. Schaff MJ, Duurland R, De Kloet ER, Vreug-denhil E: Circadian variation in BDNF mRNA expression in the rat hippocampus. Brain Res Mol Brain Res 2000; 75: 342-344.
39. Nutt D, Wilson S , Paterson L: Sleep disorders as coresymptoms of depression. Dialogues Clin Neurosci 2008; 10:329-336.
40. Antonijevic I: HPA axis and sleep: identifying subtypes of major depression. Stress 2008; 11:15-27.
41. Huber R, Tononi G, Cirelli C: Exploratory behavior, cortical BDNF expression, and sleep homeostasis. Sleep 2007; 30:129-139.
42. Onen Ser toz O, Tolga Binbay I, Koylu E , Noy-an A, Yildirim E, Elbi Mete H: The role of BDNF and HPA axis in the neurobiology of burnout syndrome. Prog Neuropsychophar-macol Biol Psychiatry 2008; 32:1459-1466.
43. Simeon D, Guralnik O, Knutelska M, Hollander E, Schmeidler J: Hypothalamic-pitu-itary-adrenal axis dysregulation in deper-sonalization disorder. Neuropsychophar-macology 2001; 25:793-795.
44. Begliuomini S, Lenzi E, Ninni F, Casarosa E, Merlini S, Pluchino N, Valentino V, Luisi S, Luisi M, Genazzani AR: Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhy t hm. J Endocrinol 2008; 197: 429-435.
45. Piccinni A, Marazziti D, Del Debbio A, Bian-chi C, Roncaglia I, Mannari C, Origlia N, Catena Dell'Osso M, Massimetti G, Do-menici L, Dell'Osso L: Diurnal variations of plasma brain-derived neurotrophic factor (BDNF) in humans. A gender analysis. Chronobiol Int 2008; 25: 819-826.
46. Martinowich K, Manji H, Lu B: New insights into BDNF function in depression and anxiety. Nat Neurosci 2007; 10:1089-1093.
47. Mannari C, Origlia N, Scatena A, Del Debbio A, Catena M, Dell'Agnello G, Barraco A, Giovannini L, Dell'Osso L, Domenici L, Pic-cinni A: BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake. Cell Mol Neurobiol 2008; 28:457-468.